Covered recipient · General Payments record
MARTHA A KIM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2023
$344.63
- Reported across 13 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $187.78 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $63.73 | 3 |
| Novo Nordisk AS | $38.70 | 2 |
| GlaxoSmithKline, LLC. | $18.65 | 1 |
| Esperion Therapeutics, Inc. | $18.07 | 1 |
| Exact Sciences Corporation | $17.39 | 1 |
| Acerta Pharma LLC | $16.17 | 1 |
| Lilly USA, LLC | $15.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $16.17 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014245853 | CMS |
| Esperion Therapeutics, Inc. | $18.07 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050753645 | CMS |
| Exact Sciences Corporation | $17.39 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026877373 | CMS |
| GlaxoSmithKline, LLC. | $18.65 | 12/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1004302805 | CMS |
| Lilly USA, LLC | $15.07 | 07/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033207509 | CMS |
| Novo Nordisk Inc | $19.46 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001991937 | CMS |
| Novo Nordisk Inc | $19.24 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1001991923 | CMS |
| PFIZER INC. | $17.78 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050376705 | CMS |
| PFIZER INC. | $20.91 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050351749 | CMS |
| PFIZER INC. | $25.04 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050415390 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.